Medline executives will present at two upcoming investor conferences in June 2026, with webcasts available online.
Quiver AI Summary
Medline Inc. announced its participation in two upcoming investor conferences, with executives scheduled to present at each event. Mike Drazin, the CFO, and Amanda Laabs, the CPO, will speak at the William Blair 46th Annual Growth Stock Conference in Chicago on June 3, 2026. Additionally, Jim Boyle, the CEO, and Drazin will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach on June 9, 2026. Webcasts of both presentations will be accessible on Medline's Investor Relations website, with replays available for 90 days after the events. Medline, headquartered in Northfield, Illinois, is the largest provider of medical-surgical products and solutions and employs over 45,000 people globally.
Potential Positives
- Participation of executive leadership in prominent investor conferences enhances Medline's visibility and credibility among investors.
- Availability of webcasts for presentations allows broader access for stakeholders to engage with the company’s strategic direction and updates.
- Being the largest provider of medical-surgical products positions Medline as a key player in the healthcare supply chain, strengthening its competitive advantage.
Potential Negatives
- Participation in major investor conferences may indicate a need to reassure investors about company performance amidst potential uncertainties.
- The announcement does not include any specific updates on financial performance or strategic initiatives, which could leave investors wanting more substantial information.
- There is no mention of recent accomplishments or competitive advantages that could enhance investor confidence, potentially reflecting a lack of positive developments at the company.
FAQ
What upcoming investor conferences will Medline executives attend?
Medline executives will present at the William Blair Growth Stock Conference and the Goldman Sachs Global Healthcare Conference.
When is Medline's presentation at the William Blair Conference?
Medline's presentation at the William Blair Conference is scheduled for June 3, 2026, at 3:40 PM ET.
Where can I find the webcasts of Medline's presentations?
The webcasts will be available on the Events page of Medline’s Investor Relations website at ir.medline.com.
How long will the webcasts of Medline's presentations be available?
The replays of Medline's webcasts will be available for 90 days following the events.
What is Medline's core business focus?
Medline is the largest provider of medical-surgical products and supply chain solutions serving healthcare providers globally.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MDLN Insider Trading Activity
$MDLN insiders have traded $MDLN stock on the open market 28 times in the past 6 months. Of those trades, 4 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:
- GROUP INC. CARLYLE has made 0 purchases and 2 sales selling 45,242,173 shares for an estimated $1,625,293,097.
- MOZART COINVESTMENT HOLDINGS, L.P. CARLYLE has made 0 purchases and 2 sales selling 45,242,173 shares for an estimated $1,625,293,097.
- & FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 7 sales selling 32,219,608 shares for an estimated $1,231,240,883.
- 8 HOLDINGS MOZART MANAGER L.L.C. BCP has made 0 purchases and 4 sales selling 27,852,986 shares for an estimated $1,128,268,756.
- MOZART ML-2 HOLDCO L.P. BX has made 0 purchases and 4 sales selling 27,852,986 shares for an estimated $1,128,268,756.
- GROUP CAYMAN INVESTMENT HOLDINGS, L.P. TC sold 26,105,840 shares for an estimated $1,070,339,440
- CIRCLE ML HOLDCO GP, LLC CP sold 26,105,840 shares for an estimated $1,070,339,440
- PRIVATE LTD GIC has made 1 purchase buying 12,586,206 shares for an estimated $364,999,974 and 1 sale selling 10,204,351 shares for an estimated $289,480,090.
- GROUP VII S1, L.L.C. TC sold 19,136,333 shares for an estimated $554,953,657
- AGGREGATOR II LP MOZART sold 13,462,600 shares for an estimated $381,911,075
- ANDREW J. MILLS purchased 2,586,206 shares for an estimated $74,999,974
- CHARLES N. MILLS has made 2 purchases buying 2,579,310 shares for an estimated $74,799,990 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MDLN Hedge Fund Activity
We have seen 258 institutional investors add shares of $MDLN stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CARLYLE GROUP INC. added 215,303,036 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,042,727,512
- VANGUARD GROUP INC added 18,887,568 shares (+inf%) to their portfolio in Q4 2025, for an estimated $793,277,856
- H&F CORPORATE INVESTORS X, LTD. removed 13,040,572 shares (-13.1%) from their portfolio in Q1 2026, for an estimated $580,305,454
- JANUS HENDERSON GROUP PLC added 10,564,621 shares (+inf%) to their portfolio in Q4 2025, for an estimated $443,714,082
- BAILLIE GIFFORD & CO added 10,410,371 shares (+inf%) to their portfolio in Q4 2025, for an estimated $437,235,582
- FMR LLC added 10,201,987 shares (+38.7%) to their portfolio in Q1 2026, for an estimated $453,988,421
- CAPITAL RESEARCH GLOBAL INVESTORS added 8,377,467 shares (+56.7%) to their portfolio in Q1 2026, for an estimated $372,797,281
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MDLN Analyst Ratings
Wall Street analysts have issued reports on $MDLN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Tigress Financial issued a "Buy" rating on 05/13/2026
- BTIG issued a "Buy" rating on 01/12/2026
- RBC Capital issued a "Outperform" rating on 01/12/2026
- Bernstein issued a "Outperform" rating on 01/12/2026
- Wolfe Research issued a "Outperform" rating on 01/12/2026
- Barclays issued a "Overweight" rating on 01/12/2026
- Citigroup issued a "Buy" rating on 01/12/2026
To track analyst ratings and price targets for $MDLN, check out Quiver Quantitative's $MDLN forecast page.
$MDLN Price Targets
Multiple analysts have issued price targets for $MDLN recently. We have seen 24 analysts offer price targets for $MDLN in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Navann Ty from BNP Paribas set a target price of $40.0 on 05/14/2026
- Ivan Feinseth from Tigress Financial set a target price of $62.0 on 05/13/2026
- David Larsen from BTIG set a target price of $55.0 on 05/07/2026
- Lee Hambright from Bernstein set a target price of $54.0 on 05/07/2026
- Patrick Donnelly from Citigroup set a target price of $55.0 on 05/07/2026
- Lisa Gill from JP Morgan set a target price of $53.0 on 03/10/2026
- Patrick Wood from Morgan Stanley set a target price of $52.0 on 03/02/2026
Full Release
NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences.
- Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.
- Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET.
Webcasts of the presentations will be available on the Events page of Medline’s Investor Relations website at ir.medline.com . Replays of the webcasts will be available on Medline’s Investor Relations website for 90 days following the events.
About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit
www.medline.com
.
Contacts
Investor Relations:
Karen King
Global Head of Investor Relations
Patrick Flaherty
Director, Investor Relations
(847) 247-7222
[email protected]
Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
[email protected]
Source: Medline Inc.
